Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for RLS in ESRD Patients
NCT01537042Phase 3Completed
- Sponsor
- UCB
- Start
- Apr 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of rotigotine in restless legs syndrome (RLS), sponsored by UCB. Started Apr 2012; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT01537042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537042.